Everolimus
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9403 publications
mTOR inhibition augments antitumor immune effector response by reprogramming the TP53 -mutant, immune-cold HNSCC tumor microenvironment.
Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026
CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.
Journal: Technology in cancer research & treatment
Published: June 17, 2026
Aspirin therapy after heart transplantation is associated with higher myocardial perfusion reserve assessed by cardiovascular magnetic resonance imaging.
Journal: JHLT open
Published: June 08, 2026
A Novel Patient-Derived Xenograft Model of Inflammatory Breast Cancer.
Journal: Research square
Published: June 04, 2026
Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors.
Journal: ESMO gastrointestinal oncology
Published: May 29, 2026
Liver Transplant Immunosuppression: Everolimus, Is it for All of Us?
Journal: Transplantation
Published: May 14, 2026
Clinical Impact and Cost-effectiveness of Everolimus Combination Therapy in Liver Transplant Recipients: Focus on the Risk of Cancer, Infection, and Renal Function.
Journal: Transplantation
Published: April 23, 2026
Retraction notice to "Effects of the combination of RAD001 and docetaxel on breast cancer stem cells" [Eur J Cancer 48 (2012) 1581-1592].
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 15, 2026
Last Updated: 06/30/2026